Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating a standardized surgical/chemotherapy approach for Type I Pleuropulmonary Blastoma and the addition of Topotecan to usual treatment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topotecan (topotecan)

Snippet

Sponsor: Children's Oncology Group | Conditions: Pleuropulmonary Blastoma | Phase 3 | Status: RECRUITING